Covid-19: Macau bought vaccines produced in China, Europe and the United States
Pharmaceutical companies Sinopharm, BioNTech and AstraZeneca were chosen to vaccinate a population in Macau against covid-19.
400,000 doses were purchased from each one, with the first expected to arrive before March. Children under 16 and pregnant women will not be vaccinated.
The Government has ordered 400,000 doses of vaccines against covid-19 from Sinopharm, BioNTech and AstraZeneca, the coordinator of the Center for Infectious Disease Prevention and Disease Surveillance announced yesterday.
One of the aspects highlighted by the Government is the power of choice resulting from the offer that will be made available. “The population can choose which vaccine they want to be administered,” said Leong Iek Hou, noting that this will only be possible when more than one type of vaccine is available.
Sinopharm vaccines – made in Beijing – are expected to arrive by March next year. Following are the messenger RNA vaccines, from BioNTech, purchased from Fosun Pharma and produced in Germany, France and Belgium. This shipment has a more indefinite arrival date, first half of next year.
The third vaccine, based on a modified adenovirus vector, is from the pharmaceutical company Astrazeneca and arrives in Macau in the second or third quarter of 2021. The sales agent is from Hong Kong, and the product is manufactured in the USA.
Read more in portuguese at Hoje Macau
This article is available in: Português